» Articles » PMID: 22680281

Development and Validation of a Measure for Intention to Adhere to HIV Treatment

Overview
Date 2012 Jun 12
PMID 22680281
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

We present the development and validation of a theory-derived scale measuring patients' behavioral intention to adhere to HIV care. Adherence to HIV care includes attendance at appointments and adherence to highly active antiretroviral therapy (HAART) regimens. These two components have been independently associated with long-term HIV outcomes. Items were chosen to reflect behavioral intention as defined by the Health Action Process Approach to health-seeking behavior. Items reflecting self-reported HIV knowledge were also included after expert panel review. The study took place from October 2009 to April 2010 at two HIV clinics in Houston, Texas. Participants were 287 adults with HIV/AIDS (10.1% female, mean age 50.8); 56.5% were African-American and 17% were Hispanic. Of the total, 87.1% were on HAART at enrollment. Factor analysis of survey items resulted in the retention of two domains, knowledge and intention, based on scree plot analysis of eigenvalues. Questions with factor loadings >0.4 were retained, yielding 4 knowledge questions and 10 intention questions. The survey had good internal consistency for knowledge (Cronbach's α=0.83) and for intention (Cronbach's α=0.81). In multivariate analysis, intention was associated with HIV viral suppression, defined as HIV-1 viral load <400 RNA copies/mL, (odds ratio [OR]=1.75, 95% .confidence interval [CI]=1.00-3.07). Knowledge was also associated with HIV suppression (OR=1.55, 95%, CI=1.09-2.12). The resulting study describes the development and preliminary validation of an HIV treatment-seeking intention measure. Additional studies are needed to validate this instrument in other populations.

Citing Articles

Leveraging Habits to Improve Adherence to Gout Medications: A Qualitative Study.

Crum K, Choudhry N, Fontanet C, Sears E, Hanken K, Lauffenburger J ACR Open Rheumatol. 2024; 6(10):625-633.

PMID: 39010675 PMC: 11471940. DOI: 10.1002/acr2.11706.


The Impact of Social Determinants of Health on Outcomes Among Individuals With HIV and Heart Failure: A Literature Review.

Borkowski P, Borkowska N Cureus. 2024; 16(3):e55913.

PMID: 38601377 PMC: 11003873. DOI: 10.7759/cureus.55913.


Construction of a questionnaire based on the Health Action Process Approach for psycho-social cognitive determinants of parents in brushing children's teeth in the Netherlands.

van Nes K, van der Ark L, van Loveren C, Aartman I PLoS One. 2023; 18(8):e0289337.

PMID: 37535634 PMC: 10399854. DOI: 10.1371/journal.pone.0289337.


HIV-Specific Reported Outcome Measures: Systematic Review of Psychometric Properties.

Wang Z, Zhu Y, Duan X, Kang H, Qu B JMIR Public Health Surveill. 2022; 8(12):e39015.

PMID: 36222289 PMC: 9782451. DOI: 10.2196/39015.


A Qualitative Study Exploring Factors Associated with Retention in HIV Care among Women with HIV in a Large HIV Clinic in Lagos, Nigeria, after Implementing the Test and Treat Policy.

Odediran O, Odukoya O, Balogun M, Colasanti J, Akanmu A AIDS Res Treat. 2022; 2022:9074844.

PMID: 35983188 PMC: 9381265. DOI: 10.1155/2022/9074844.


References
1.
Barclay T, Hinkin C, Castellon S, Mason K, Reinhard M, Marion S . Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007; 26(1):40-9. PMC: 2863998. DOI: 10.1037/0278-6133.26.1.40. View

2.
Ickovics J, Meade C . Adherence to HAART among patients with HIV: breakthroughs and barriers. AIDS Care. 2002; 14(3):309-18. DOI: 10.1080/09540120220123685. View

3.
Grimes R, Grimes D . Readiness: the state of the science (or the lack thereof). Curr HIV/AIDS Rep. 2010; 7(4):245-52. PMC: 2989238. DOI: 10.1007/s11904-010-0056-2. View

4.
Wainberg M, Friedland G . Public health implications of antiretroviral therapy and HIV drug resistance. JAMA. 1998; 279(24):1977-83. DOI: 10.1001/jama.279.24.1977. View

5.
Giordano T, Suarez-Almazor M, Grimes R . The population effectiveness of highly active antiretroviral therapy: are good drugs good enough?. Curr HIV/AIDS Rep. 2005; 2(4):177-83. DOI: 10.1007/s11904-005-0013-7. View